| Sector |
Capital Goods
|
Compare with Sector peers |
| Industry |
Engineering - Industrial Equipments
|
Compare with Industry peers |
| Website | http://www.dilindia.co.in | |
| Market Cap | 218.99 Cr. | |
| Enterprise Value(EV) | 222.36 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 86.57 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 8.43 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 60.85 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 647.03 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.13 | Calculated using Price: 729.95 |
| Dividend Yield | 0.55 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.30 Cr. | 3,000,000 Shares |
| FaceValue | 10 | |
| About DHP India Ltd. | ||
| DHP India was incorporated on April 26, 1991 as a private limited company and got converted into a public limited company on April 7, 1995. | ||
| 1 Day |
|
+1.68% |
| 1 Week |
|
-0.22% |
| 1 Month |
|
+1.27% |
| 3 Month |
|
-8.92% |
| 6 Month |
|
-10.98% |
| 1 Year |
|
-25.52% |
| 2 Year |
|
-4.37% |
| 5 Year |
|
+33.28% |
| 10 Year |
|
+1090.78% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 19.88 | 14.54 | 26.53 | 24.46 | 19.85 | 4.43 | 26.01 | 27.46 | 14.51 | |
| Return on Capital Employed (%) | 27.58 | 18.6 | 35.46 | 30.32 | 26.43 | 9.16 | 31.63 | 35.8 | 19.65 | |
| Return on Assets (%) | 15.08 | 11.66 | 22.3 | 20.94 | 17.09 | 3.87 | 23.06 | 23.84 | 12.93 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 32 | 36 | 47 | 59 | 71 | 69 | 109 | 150 | 173 | 194 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | -2 | 2 | 3 | 3 | 3 | |
| Curr. Liab. | 10 | 8 | 8 | 10 | 12 | 10 | 12 | 22 | 12 | 8 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 41 | 43 | 55 | 68 | 83 | 77 | 124 | 175 | 187 | 205 | |
| Non Curr. Assets | 13 | 12 | 12 | 12 | 15 | 10 | 10 | 20 | 27 | 27 | |
| Curr. Assets | 28 | 31 | 43 | 56 | 68 | 67 | 113 | 155 | 161 | 178 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 41 | 43 | 55 | 68 | 83 | 77 | 124 | 175 | 187 | 205 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 41 | 37 | 47 | 52 | 67 | 56 | 70 | 120 | 109 | 52 | |
| Other Income | 1 | 3 | 5 | 6 | 2 | 3 | 1 | 10 | 2 | 26 | |
| Total Income | 42 | 39 | 52 | 58 | 69 | 59 | 72 | 130 | 111 | 78 | |
| Total Expenditure | -31 | -31 | -35 | -40 | -49 | -42 | -50 | -81 | -76 | -45 | |
| PBIDT | 11 | 8 | 17 | 18 | 19 | 17 | 22 | 49 | 35 | 33 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | -2 | -2 | -1 | -1 | -1 | -2 | -2 | -2 | -3 | -4 | |
| Taxation | -3 | -2 | -4 | -4 | -5 | -3 | -5 | -11 | -8 | -4 | |
| Exceptional Items | -8 | 8 | |||||||||
| PAT | 6 | 5 | 11 | 13 | 13 | 3 | 23 | 36 | 23 | 26 | |
| Adjusted EPS | 19 | 16 | 37 | 43 | 43 | 10 | 77 | 119 | 78 | 87 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 6 | 9 | 6 | 7 | 6 | 13 | 15 | 6 | 8 | 43 | |
| Cash Fr. Inv. | -5 | -9 | -5 | -7 | -6 | -12 | -6 | -9 | -7 | -38 | |
| Cash Fr. Finan. | 0 | 1 | -2 | -2 | 0 | -1 | -2 | -2 | -2 | -2 | |
| Net Change | 1 | 0 | 0 | -2 | 1 | 0 | 7 | -5 | -1 | 4 | |
| Cash & Cash Eqvt | 2 | 2 | 2 | 0 | 1 | 0 | 7 | 2 | 2 | 5 |
|
Tue, 30 Apr 2024
Todays Board Meting 30-04-2024 Approve The Reaappointment Of Mr.Asheesh Dabriwal As MD And Mr.Buddhedeb Basu & Dr.Subrata Haldar As Non-Ex.Ind.Director For 5 Years Todays Board Meeting dated 30-04-2024 approve the reapoointment of Mr.Ashesh Dabriwal as Managing Director with a revided Remuneration terms etc. for 5 years from 30/04/2024 to 29/04/2029 and todays also approve the Board for reappointment of Mr.Buddhadeb Basu & Dr.Subrata Haldar as Non-Executive Independent Director for a period of 5 years from 30/04/2024 to 29/04/2029 (Earlier all three person retired from the company w.e.f 31/03/2024 now the same reapoointed wef 30/04/2024). The above appointment is subject to approval of shareholders in ensuing AGM/EGM etc. |
|
Tue, 30 Apr 2024
Board Meeting Outcome for Outcome Of Board Meeting Dated 30-04-2024 (Started At 1.30 PM & Concluded At 2.00 PM) For Approval Of Reappt Of Mr.Asheesh Dabriwal As MD & Reappoint Of Mr.Buddhadeb Basu & Dr.Subrata Haldar As NED Indep.Director For 5 Years Period Outcome of Board Meeting dated 30-04-2024 (Started at 1.30 PM & Concluded at 2.00 PM) for approval of Reappointment of Mr.Asheesh Dabriwal as Managing Director (with a revised terms condition and Remuneration Agreement) & Reappointment of Mr.Buddhadeb Basu & Dr.Subrata Haldar as Non-Executive Independent Director for 5 years period (from 30-04-2024 to 29-05-2029) subject to approval of shareholders in ensuing AGM/EGM etc. |
|
Tue, 30 Apr 2024
Announcement under Regulation 30 (LODR)-Change in Management Todays Board meeting held on 30-04-2024 approved the Reapoointment of Mr.Asheesh Dabriwal as managing Director of the Company for a period of 5 years from 30/04/2024 to 29/04/2029 with a revised Remuneration Agreement and Todays also approve the reappointment of Mr.Buddhadeb basu & Dr. Subrata Haldar as Non-Executive Independent Director of the Company for period of 5 years from 30/04/2024 to 29/04/2029 (all three person retired from the Board on 31/03/2024 and hence same all three person reappointed on 30/04/2024 subject to approval of shareholders in ensuing AGM/EGM etc.) |
| Fri, 03 May 2024 |
High Delivery Percentage
|
Opening at High
|
Closing Above Previous High
|
Close Within 52 Week Low Zone
|
CCI Trending Up
|
